Copyright Reports & Markets. All rights reserved.

Global Neurovascular Thrombectomy Device Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Neurovascular Thrombectomy Device Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Neurovascular Thrombectomy Device Market Size Growth Rate by Product
      • 1.4.2 Mechanical/Fragmentation Thrombectomy Devices
      • 1.4.3 Stent Retrievers
      • 1.4.4 Basket/Brush Retrievers
      • 1.4.5 Coil Retrievers
      • 1.4.6 Aspiration Thrombectomy Devices
      • 1.4.7 Rheolytic/Hydrodynamic Thrombectomy Devices
      • 1.4.8 Ultrasonic Thrombectomy Devices
    • 1.5 Market by End User
      • 1.5.1 Global Neurovascular Thrombectomy Device Market Size Growth Rate by End User
      • 1.5.2 Hospitals and Surgical Centers
      • 1.5.3 Ambulatory Surgical Centers
      • 1.5.4 Research Laboratories & Academic Institutes
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Neurovascular Thrombectomy Device Market Size
      • 2.1.1 Global Neurovascular Thrombectomy Device Revenue 2014-2025
      • 2.1.2 Global Neurovascular Thrombectomy Device Sales 2014-2025
    • 2.2 Neurovascular Thrombectomy Device Growth Rate by Regions
      • 2.2.1 Global Neurovascular Thrombectomy Device Sales by Regions
      • 2.2.2 Global Neurovascular Thrombectomy Device Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Neurovascular Thrombectomy Device Sales by Manufacturers
      • 3.1.1 Neurovascular Thrombectomy Device Sales by Manufacturers
      • 3.1.2 Neurovascular Thrombectomy Device Sales Market Share by Manufacturers
      • 3.1.3 Global Neurovascular Thrombectomy Device Market Concentration Ratio (CR5 and HHI)
    • 3.2 Neurovascular Thrombectomy Device Revenue by Manufacturers
      • 3.2.1 Neurovascular Thrombectomy Device Revenue by Manufacturers (2014-2019)
      • 3.2.2 Neurovascular Thrombectomy Device Revenue Share by Manufacturers (2014-2019)
    • 3.3 Neurovascular Thrombectomy Device Price by Manufacturers
    • 3.4 Neurovascular Thrombectomy Device Manufacturing Base Distribution, Product Types
      • 3.4.1 Neurovascular Thrombectomy Device Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Neurovascular Thrombectomy Device Product Type
      • 3.4.3 Date of International Manufacturers Enter into Neurovascular Thrombectomy Device Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Neurovascular Thrombectomy Device Sales by Product
    • 4.2 Global Neurovascular Thrombectomy Device Revenue by Product
    • 4.3 Neurovascular Thrombectomy Device Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Neurovascular Thrombectomy Device Breakdown Data by End User

    6 North America

    • 6.1 North America Neurovascular Thrombectomy Device by Countries
      • 6.1.1 North America Neurovascular Thrombectomy Device Sales by Countries
      • 6.1.2 North America Neurovascular Thrombectomy Device Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Neurovascular Thrombectomy Device by Product
    • 6.3 North America Neurovascular Thrombectomy Device by End User

    7 Europe

    • 7.1 Europe Neurovascular Thrombectomy Device by Countries
      • 7.1.1 Europe Neurovascular Thrombectomy Device Sales by Countries
      • 7.1.2 Europe Neurovascular Thrombectomy Device Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Neurovascular Thrombectomy Device by Product
    • 7.3 Europe Neurovascular Thrombectomy Device by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Neurovascular Thrombectomy Device by Countries
      • 8.1.1 Asia Pacific Neurovascular Thrombectomy Device Sales by Countries
      • 8.1.2 Asia Pacific Neurovascular Thrombectomy Device Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Neurovascular Thrombectomy Device by Product
    • 8.3 Asia Pacific Neurovascular Thrombectomy Device by End User

    9 Central & South America

    • 9.1 Central & South America Neurovascular Thrombectomy Device by Countries
      • 9.1.1 Central & South America Neurovascular Thrombectomy Device Sales by Countries
      • 9.1.2 Central & South America Neurovascular Thrombectomy Device Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Neurovascular Thrombectomy Device by Product
    • 9.3 Central & South America Neurovascular Thrombectomy Device by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Neurovascular Thrombectomy Device by Countries
      • 10.1.1 Middle East and Africa Neurovascular Thrombectomy Device Sales by Countries
      • 10.1.2 Middle East and Africa Neurovascular Thrombectomy Device Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Neurovascular Thrombectomy Device by Product
    • 10.3 Middle East and Africa Neurovascular Thrombectomy Device by End User

    11 Company Profiles

    • 11.1 Stryker Corporation (U.S.)
      • 11.1.1 Stryker Corporation (U.S.) Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Products Offered
      • 11.1.5 Stryker Corporation (U.S.) Recent Development
    • 11.2 Medtronic plc (Ireland)
      • 11.2.1 Medtronic plc (Ireland) Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Products Offered
      • 11.2.5 Medtronic plc (Ireland) Recent Development
    • 11.3 Boston Scientific Corporation (U.S.)
      • 11.3.1 Boston Scientific Corporation (U.S.) Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Products Offered
      • 11.3.5 Boston Scientific Corporation (U.S.) Recent Development
    • 11.4 Johnson & Johnson (U.S.)
      • 11.4.1 Johnson & Johnson (U.S.) Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Products Offered
      • 11.4.5 Johnson & Johnson (U.S.) Recent Development
    • 11.5 Terumo Corporation (Japan)
      • 11.5.1 Terumo Corporation (Japan) Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Products Offered
      • 11.5.5 Terumo Corporation (Japan) Recent Development
    • 11.6 Penumbra, Inc. (U.S.)
      • 11.6.1 Penumbra, Inc. (U.S.) Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Products Offered
      • 11.6.5 Penumbra, Inc. (U.S.) Recent Development
    • 11.7 Spectranetics Corporation (U.S.)
      • 11.7.1 Spectranetics Corporation (U.S.) Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Products Offered
      • 11.7.5 Spectranetics Corporation (U.S.) Recent Development
    • 11.8 Edwards Lifesciences Corporation (U.S.)
      • 11.8.1 Edwards Lifesciences Corporation (U.S.) Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Products Offered
      • 11.8.5 Edwards Lifesciences Corporation (U.S.) Recent Development
    • 11.9 Argon Medical Devices, Inc. (U.S.)
      • 11.9.1 Argon Medical Devices, Inc. (U.S.) Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Products Offered
      • 11.9.5 Argon Medical Devices, Inc. (U.S.) Recent Development
    • 11.10 Teleflex Incorporated (U.S.)
      • 11.10.1 Teleflex Incorporated (U.S.) Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Products Offered
      • 11.10.5 Teleflex Incorporated (U.S.) Recent Development

    12 Future Forecast

    • 12.1 Neurovascular Thrombectomy Device Market Forecast by Regions
      • 12.1.1 Global Neurovascular Thrombectomy Device Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Neurovascular Thrombectomy Device Revenue Forecast by Regions 2019-2025
    • 12.2 Neurovascular Thrombectomy Device Market Forecast by Product
      • 12.2.1 Global Neurovascular Thrombectomy Device Sales Forecast by Product 2019-2025
      • 12.2.2 Global Neurovascular Thrombectomy Device Revenue Forecast by Product 2019-2025
    • 12.3 Neurovascular Thrombectomy Device Market Forecast by End User
    • 12.4 North America Neurovascular Thrombectomy Device Forecast
    • 12.5 Europe Neurovascular Thrombectomy Device Forecast
    • 12.6 Asia Pacific Neurovascular Thrombectomy Device Forecast
    • 12.7 Central & South America Neurovascular Thrombectomy Device Forecast
    • 12.8 Middle East and Africa Neurovascular Thrombectomy Device Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Neurovascular Thrombectomy Device Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Neurovascular Thrombectomy Device market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Neurovascular Thrombectomy Device market based on company, product type, end user and key regions.

      This report studies the global market size of Neurovascular Thrombectomy Device in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neurovascular Thrombectomy Device in these regions.
      This research report categorizes the global Neurovascular Thrombectomy Device market by top players/brands, region, type and end user. This report also studies the global Neurovascular Thrombectomy Device market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Stryker Corporation (U.S.)
      Medtronic plc (Ireland)
      Boston Scientific Corporation (U.S.)
      Johnson & Johnson (U.S.)
      Terumo Corporation (Japan)
      Penumbra, Inc. (U.S.)
      Spectranetics Corporation (U.S.)
      Edwards Lifesciences Corporation (U.S.)
      Argon Medical Devices, Inc. (U.S.)
      Teleflex Incorporated (U.S.)

      Market size by Product
      Mechanical/Fragmentation Thrombectomy Devices
      Stent Retrievers
      Basket/Brush Retrievers
      Coil Retrievers
      Aspiration Thrombectomy Devices
      Rheolytic/Hydrodynamic Thrombectomy Devices
      Ultrasonic Thrombectomy Devices
      Market size by End User
      Hospitals and Surgical Centers
      Ambulatory Surgical Centers
      Research Laboratories & Academic Institutes
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Neurovascular Thrombectomy Device market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Neurovascular Thrombectomy Device market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Neurovascular Thrombectomy Device companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Neurovascular Thrombectomy Device submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Neurovascular Thrombectomy Device are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neurovascular Thrombectomy Device market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now